Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.
Saved in:
| Title: | Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study. |
|---|---|
| Authors: | Macaluso FS; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Fries W; Inflammatory Bowel Disease Unit, 'G. Martino' Hospital, Messina, Italy., Viola A; Inflammatory Bowel Disease Unit, 'G. Martino' Hospital, Messina, Italy., Cappello M; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy., Melatti P; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy., Mocciaro F; Gastroenterology and Endoscopy Unit, 'ARNAS Civico-Di Cristina-Benfratelli' Hospital, Palermo, Italy., Scrivo B; Gastroenterology and Endoscopy Unit, 'ARNAS Civico-Di Cristina-Benfratelli' Hospital, Palermo, Italy., Di Caro S; Gastroenterology and Endoscopy Unit, 'S. Antonio Abate' Hospital, Trapani, Italy., Muscarella S; Gastroenterology and Endoscopy Unit, 'S. Antonio Abate' Hospital, Trapani, Italy., Ferracane C; Gastroenterology Unit, 'Vittorio Emanuele' Hospital, Catania, Italy., Giangreco E; Gastroenterology Unit, 'Guzzardi' Hospital, Vittoria, Italy., Minissale MG; Gastroenterology and Endoscopy Unit, 'Buccheri La Ferla Fatebenefratelli' Hospital, Palermo, Italy., Grova M; Endoscopy Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Li Voti R; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Mistretta G; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Renna S; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Casà A; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Armetta S; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Morello S; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy., Orlando A; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy. |
| Corporate Authors: | Sicilian Network for Inflammatory Bowel Disease |
| Source: | Journal of Crohn's & colitis [J Crohns Colitis] 2025 Nov 08; Vol. 19 (10). |
| Publication Type: | Journal Article; Observational Study; Comparative Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41081746 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Macaluso+FS%22">Macaluso FS</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Fries+W%22">Fries W</searchLink>; Inflammatory Bowel Disease Unit, 'G. Martino' Hospital, Messina, Italy.<br /><searchLink fieldCode="AU" term="%22Viola+A%22">Viola A</searchLink>; Inflammatory Bowel Disease Unit, 'G. Martino' Hospital, Messina, Italy.<br /><searchLink fieldCode="AU" term="%22Cappello+M%22">Cappello M</searchLink>; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Melatti+P%22">Melatti P</searchLink>; Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Mocciaro+F%22">Mocciaro F</searchLink>; Gastroenterology and Endoscopy Unit, 'ARNAS Civico-Di Cristina-Benfratelli' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Scrivo+B%22">Scrivo B</searchLink>; Gastroenterology and Endoscopy Unit, 'ARNAS Civico-Di Cristina-Benfratelli' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Caro+S%22">Di Caro S</searchLink>; Gastroenterology and Endoscopy Unit, 'S. Antonio Abate' Hospital, Trapani, Italy.<br /><searchLink fieldCode="AU" term="%22Muscarella+S%22">Muscarella S</searchLink>; Gastroenterology and Endoscopy Unit, 'S. Antonio Abate' Hospital, Trapani, Italy.<br /><searchLink fieldCode="AU" term="%22Ferracane+C%22">Ferracane C</searchLink>; Gastroenterology Unit, 'Vittorio Emanuele' Hospital, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Giangreco+E%22">Giangreco E</searchLink>; Gastroenterology Unit, 'Guzzardi' Hospital, Vittoria, Italy.<br /><searchLink fieldCode="AU" term="%22Minissale+MG%22">Minissale MG</searchLink>; Gastroenterology and Endoscopy Unit, 'Buccheri La Ferla Fatebenefratelli' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Grova+M%22">Grova M</searchLink>; Endoscopy Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Li+Voti+R%22">Li Voti R</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Mistretta+G%22">Mistretta G</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Renna+S%22">Renna S</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Casà+A%22">Casà A</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Armetta+S%22">Armetta S</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Morello+S%22">Morello S</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Orlando+A%22">Orlando A</searchLink>; Inflammatory Bowel Disease Unit, 'Villa Sofia-Cervello' Hospital, Palermo, Italy. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Sicilian+Network+for+Inflammatory+Bowel+Disease%22">Sicilian Network for Inflammatory Bowel Disease</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101318676%22">Journal of Crohn's & colitis</searchLink> [J Crohns Colitis] 2025 Nov 08; Vol. 19 (10). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101318676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1876-4479 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218739946%22">18739946 </searchLink><i>NLM ISO Abbreviation: </i>J Crohns Colitis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41081746 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ecco-jcc/jjaf175 Languages: – Code: eng Text: English Titles: – TitleFull: Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Macaluso FS – PersonEntity: Name: NameFull: Fries W – PersonEntity: Name: NameFull: Viola A – PersonEntity: Name: NameFull: Cappello M – PersonEntity: Name: NameFull: Melatti P – PersonEntity: Name: NameFull: Mocciaro F – PersonEntity: Name: NameFull: Scrivo B – PersonEntity: Name: NameFull: Di Caro S – PersonEntity: Name: NameFull: Muscarella S – PersonEntity: Name: NameFull: Ferracane C – PersonEntity: Name: NameFull: Giangreco E – PersonEntity: Name: NameFull: Minissale MG – PersonEntity: Name: NameFull: Grova M – PersonEntity: Name: NameFull: Li Voti R – PersonEntity: Name: NameFull: Mistretta G – PersonEntity: Name: NameFull: Renna S – PersonEntity: Name: NameFull: Casà A – PersonEntity: Name: NameFull: Armetta S – PersonEntity: Name: NameFull: Morello S – PersonEntity: Name: NameFull: Orlando A IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 11 Text: 2025 Nov 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1876-4479 Numbering: – Type: volume Value: 19 – Type: issue Value: 10 Titles: – TitleFull: Journal of Crohn's & colitis Type: main |
| ResultId | 1 |
